BioStem Technologies Inc BSEM
News
BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sidoti Events, LLC's August Micro-Cap Virtual Conference
BioStem Technologies to Present at the Sidoti MicroCap Conference
BioStem Technologies Reports Second Quarter 2026 Financial Results
